The Global AcuteOtitis Media Treatment Market, By Drug Type (Antibiotics, Nonsteroidalanti-Inflammatory Drug, Analgesic, and Anaesthetic), By Formulation (Oral andTopical), By Distribution Channel (Hospitals, Retail Pharmacies, and OnlinePharmacies), and by Region (North America, Latin America, Europe, Asia Pacific,the Middle East, and Africa) was valued at US$ 2,043.3 million in 2016 and isprojected to exhibit a CAGR of 5.1% over the forecast period (2017 – 2025).
Increasing prevalence of acuteotitis media is expected to be a major factor in growth of acute otitis mediatreatment market. According to an article published in PLOS ONE Journal in2012, acute otitis media incidence rate is about 10.9% and around 709 millionpeople suffer from this diseases each year. Of these, children under the age of5 account for around 51%. Increasing prevalence of acute otitis media amongchildren is expected to lead to increasing demand for treatment.
Acute otitis media (AOM) is atype of ear infection in which air-filled space behind the eardrum (the middleear) is infected and causes pain and general symptoms of illness such as fever,irritability and problem in sleeping. AOM is a most common ear infections amongchildren as the Eustachian tube is shorter as compared to adults, which makesit more accessible to bacteria and viruses. Bacteria such as Streptococcuspneumoniae (strep) and Hemophilus influenzae (H. flu) account for around 85% ofcases of AOM and viruses account for only 15% of these cases.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1333
Browse 36 Market Data Tables and42 Figures spread through 178 Pages and in-depth TOC on Acute Otitis MediaTreatment Market by Drug Type (Antibiotics, Nonsteroidal anti-Inflammatorydrug, Analgesic, and Anaesthetic), By Formulation (Oral, and Topical), By EndUser (Hospitals, Retail pharmacies, and Online pharmacies) and Region (NorthAmerica, Latin America, Europe, Asia Pacific, the Middle East, and Africa) -Global Forecast to 2025.
Key players in the acute otitismedia treatment market are focusing on launching multiple products.Laboratorios SALVAT S.A. and Arbor Pharmaceuticals, LLC launched OTOVEL(ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 %) and the solutionindicated for the treatment of acute otitis media. Increasing product approvalsis another factor expected to aid in growth of the market. For instance, in2017, Committee for Medicinal Products for Human Use (CHMP) of the EuropeanMedicines Agency (EMA) issued a positive opinion on GlaxoSmithKline plc. newfour-dose vial of Synflorix pneumococcal vaccine indicated for active immunisationagainst acute otitis media. In 2013, Pfizer Inc. received European approval toexpand use of its Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine)for adults aged 18 to 49 years for the prevention of invasive disease,pneumonia and acute otitis media caused by Streptococcus pneumonia. In 2015,Otonomy, Inc. received U.S. Food and Drug Administration (FDA) approval for itsOTIPRIO (ciprofloxacin otic suspension) used in the treatment of AOM.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/acute-otitis-media-treatment-market-1333
Key Takeaways of the Acute OtitisMedia Treatment Market:
The global acute otitis mediatreatment market is expected to exhibit a CAGR of 5.1% over the forecast period(2017–2025), owing to increasing approvals by regulatory bodies to innovativeproducts for treatment of AOM.
North America was the dominantregion in the market and is expected to continue its dominance over theforecast period (2017–2025). This is owing to increasing prevalence of acuteotitis media and launches of novel drugs for the treatment of acute otitismedia in the region.
Key players are focusing onexpanding its market presence by launching novel drugs and receiving marketingapprovals of their new products in key geographies
Major players operating in theacute otitis media treatment market include Pfizer, Inc., Eli Lilly andCompany, Abbott Laboratories, GlaxoSmithKline plc., Bayer AG, Novartis AG,Pediapharm Inc., Sanofi S.A., and Bristol Myers Squibb Company.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1333
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
